Financial Daily from THE HINDU group of publications
Sunday, February 16, 2003

News
Features
Stocks
Port Info
Archives


Subscription

Group Sites

MARKETS

MUTUAL FUNDS


Zurich India Top 200 Fund: Invest
IN TERMS of its portfolio strategy, the Zurich India Top 200 Fund lies midway between aggressive equity funds, which rely wholly on the stock selection skills of their fund manager, and passive index funds, which merely mimic the returns on stock ... More

Tata MF's Ind Tax Shield: Positioned differently now
TATA Mutual Fund's Ind Tax Shield is to become an open-ended scheme with effect from March 31, 2003. The fund, in its new avatar, will be called the Tata Opportunities Fund. It was taken over from Ind Bank Mutual Fund and was a tax savings fund. ... More

US-64 trades: Senseless or sinister?
WILL you buy a product that is worth only Rs 12 for Rs 14? If the secondary market trading in US-64 is any indication, it appears that investors do indulge in such transactions. There are three categories of US-64 units: Units worth Rs 12; ... More

Prudential ICICI Power: Hold
INVESTORS in Prudential ICICI Power can hold on to their investments. The performance of the fund in the last 12 months has been impressive. Fresh investments however need not be considered now. It would be better to let the fund accumulate a ... More

Zurich India Capital Builder: Sell
INVESTORS in Zurich India Capital Builder can think of paring exposures in the fund, as its track record has become rather unimpressive. It may have stayed ahead of the broad market, but a comparison with peer funds does not portray Capital ... More

Franklin Prima: Invest
FRESH investments can be contemplated in Franklin Prima, an open-end fund that focusses sharply on mid-cap and some small-cap stocks. The fund has an impressive track record stretching back to five years, even since its launch in 1993. It did ... More

STOCK MARKETS


World Cup snips bourses' turnover
IF capturing eyeballs is what broadcasters want, then stock market functionaries did not disappoint them last week. With turnover and volumes down by 20 per cent on both the BSE and NSE, ever since the World Cup began, the Indian stock ... More

DERIVATIVES MARKETS


Basics of Nifty futures
A FUTURES contract is a forward contract, which is traded on an Exchange. NSE commenced trading in index futures on June 12, 2000. The index futures contracts are based on the popular market benchmark S&P CNX Nifty index.NSE defines the ... More

HPCL calls remain firm
THE spot market languished as fear of war in West Asia pushed down the share prices during the week. The undertone remained bearish as institutional investors (both Indian and foreign) adopted cautious approach and refrained themselves from ... More

REGULATORY BODIES & RULINGS


`Portfolio managers can deal in derivatives thru stock exchanges'
PROVIDING clarity to the recent amendments to the regulations on portfolio managers, the Securities and Exchange Board of India (SEBI) said that the portfolio managers were permitted to invest in derivatives, including transactions for the ... More

COMMENTARY


HLL: On the verge of an uptrend
NIFTY (1036): The growing threat of a US-led attack on Iraq continued to dominate proceedings during the week gone by. As mentioned last week, the drop below 1045 imparted bearish trend, pushing the Nifty to a low of 1034.1 on ... More

Reduce exposure in United Phosphorous
THE stock market sentiment continued to be overshadowed by the uncertain geopolitical environment that prevailed in the gulf region. The possibility of a US-led attack on Iraq kept market operators from building huge positions. Sensex ... More

Nasdaq: Short-term recovery
AFTER a subdued trend during the week, the American stock market saw a sharp recovery on Friday. The improved earnings performance of computer major - Dell Computer played a key role in imparting positive sentiment. Besides, the threat of ... More

Market rumours on ADR issue pull Infosys down
Infosys Technologies (Rs 4,156): The stock price of software major Infosys Technologies went down this week by 7.2 per cent. This has to be viewed in the backdrop of market rumours, that the company is likely to defer its proposed ... More

RECOMMENDATION


Dabur India: Buy
FOR a company which combines a formidable array of FMCG and ayurvedic healthcare brands in its portfolio and also manages a thriving pharmaceutical business, Dabur India has not enjoyed a very high stock valuation on the bourses. It trades at a ... More

Grasim: Hold
GRASIM Industries shareholders can stay invested as there may be room for value gains on the back of improving fundamentals. Any decision by SEBI to allow the open offer for Larsen & Toubro to go through at Rs 190 per share may be a long-term ... More

Henkel SPIC: Pare exposures
REFLECTIVE of the overall unfavourable business phase in the FMCG sector, Henkel SPIC has come up with a flat trend in earnings. But the performance is not all that alarming if viewed in the backdrop of the depressed business environment and the ... More

A complex game waiting to be played out
IOC: Hold
HPCL: Buy
BPCL: Sell
Reliance: Hold More

Aventis Pharma: Hold
AVENTIS Pharma's share price trades at around Rs 260, close to its 52-week low. Over the last year, it has lost over 30 per cent. The significant erosion has made it necessary to revisit the ... More

TVS Srichakra: Book profits
THE sustained increase in two-wheeler production has had a positive impact on quite a few companies including TVS Srichakra. Considering the recent rise in share price and firm trend in price of key inputs, including natural rubber, shareholders ... More

ABB India: Good medium term bet
AT the current market price of Rs 295, ABB appears to be a good bet in the medium term. Investors who have missed the rally in the past couple of months can still contemplate fresh exposures in the stock. Strong fundamentals, steady growth in the ... More

PUBLIC OFFERS


Divi's Labs: Reactive
INVESTORS can consider subscribing to the public offer of the Hyderabad-based Divi's Laboratories at the floor price of Rs 130. The company derives a substantial portion of its revenues by supplying active pharmaceutical ingredients (API) to drug ... More
Stock Quotes
SE Diary
Comments & Letters to the Editor to: bleditor@thehindu.co.in
Subscribe to: Business Line
BL Free Trial

It Adds Up eBook

Pick a Winner Stock Market Contest

Top Stories
HAL, Russia drawing up plans for aircraft project


Regulating pesticides — When a ban is not actually a ban

`Portfolio managers can deal in derivatives thru stock exchanges'

Gold may lose more sheen on Blix report

In Focus
Kelkar Report
Telecom Competition
Oil PSUs: Disinvestment dilemma
Housing Fin. rate war: Bonanza for consumers!
NPAs in Banking
In Depth
Simple Economics
Consumer Notes
Tax Talk
The Brahmananda collections
2002: A drought year
Gold: Still the winner?
Cars: Always a beauty
Books and Reviews
Looking back
Feb. 9-Feb. 15
`Market rewards performing cos' — Mr Raamdeo Agrawal, Joint MD, Motilal Oswal Securities

E-balance sheets on cards?


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | Home |

Copyright © 2003, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line